Carmel Pharma, Inc. will introduce the new Injector N35 with ErgoMotion™ at the 33rd ONS Annual Congress in Philadelphia, PA.
This new component employs the innovative and unique technology of ErgoMotion™ - a simple turn-key motion that provides easy access during hazardous drug preparation... - May 16, 2008
Scientists recently released the results of the first ever national survey which assessed nurses’ extent and frequency of exposures to common health care hazards. - December 19, 2007
Today, Carmel Pharma, Inc. introduces the Injector Luer Lock N35 with ErgoMotion™ during the 42nd ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV. - December 03, 2007
Carmel Pharma, manufacturer and distributor of PhaSeal, announced that they are sponsoring a live, accredited continuing education (CE) seminar during this year’s 42nd Annual ASHP Midyear Clinical Meeting and Exhibition in Las Vegas, NV in December. - November 09, 2007
New evidence-based research was presented at ONS Congress by MD Anderson and the University of Utah which concluded only the PhaSeal System confined the drug, thus proving the prevention of drug exposure from preparation through administration of hazardous drugs. - May 05, 2007
Carmel Pharma, Inc. launches their new Protector 28 (P28). This preparation component is the latest advancement of the PhaSeal System and is available now. - May 03, 2007
Carmel Pharma, manufacturers and distributors of PhaSeal, announced today that they are now offering an accredited continuing education (CE) program developed by STAT Educational Services, an accredited provider of continuing education for various healthcare professionals. - April 25, 2007
New evidence-based research for determining adherence to the NIOSH definition of a closed-system will be unveiled during ‘Ask the Experts’ at the ONS Congress on Wednesday, April 25 in Las Vegas, NV.
‘Ask the Experts’ will be held from 1pm-2pm on Wednesday, April 25 in the Carmel... - April 04, 2007
